These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9790920)

  • 1. Human microvascular endothelial cells are strongly sensitive to Shiga toxins.
    Ohmi K; Kiyokawa N; Takeda T; Fujimoto J
    Biochem Biophys Res Commun; 1998 Oct; 251(1):137-41. PubMed ID: 9790920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shiga/verocytotoxins and Shiga/verotoxigenic Escherichia coli in animals.
    Mainil J
    Vet Res; 1999; 30(2-3):235-57. PubMed ID: 10367357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shiga toxins induce apoptosis in pulmonary epithelium-derived cells.
    Uchida H; Kiyokawa N; Taguchi T; Horie H; Fujimoto J; Takeda T
    J Infect Dis; 1999 Dec; 180(6):1902-11. PubMed ID: 10558947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of Shiga toxins with human brain microvascular endothelial cells: cytokines as sensitizing agents.
    Ramegowda B; Samuel JE; Tesh VL
    J Infect Dis; 1999 Oct; 180(4):1205-13. PubMed ID: 10479149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shiga toxins, glycosphingolipid diversity, and endothelial cell injury.
    Müthing J; Schweppe CH; Karch H; Friedrich AW
    Thromb Haemost; 2009 Feb; 101(2):252-64. PubMed ID: 19190807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary cultures of human endothelial cells are susceptible to low doses of Shiga toxins and undergo apoptosis.
    Yoshida T; Fukada M; Koide N; Ikeda H; Sugiyama T; Kato Y; Ishikawa N; Yokochi T
    J Infect Dis; 1999 Dec; 180(6):2048-52. PubMed ID: 10558968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the role of Shiga and Shiga-like toxins in mediating direct damage to human vascular endothelial cells.
    Tesh VL; Samuel JE; Perera LP; Sharefkin JB; O'Brien AD
    J Infect Dis; 1991 Aug; 164(2):344-52. PubMed ID: 1649877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shiga toxin-associated hemolytic uremic syndrome: interleukin-1 beta enhancement of Shiga toxin cytotoxicity toward human vascular endothelial cells in vitro.
    Kaye SA; Louise CB; Boyd B; Lingwood CA; Obrig TG
    Infect Immun; 1993 Sep; 61(9):3886-91. PubMed ID: 8359910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct cytotoxic action of Shiga toxin on human vascular endothelial cells.
    Obrig TG; Del Vecchio PJ; Brown JE; Moran TP; Rowland BM; Judge TK; Rothman SW
    Infect Immun; 1988 Sep; 56(9):2373-8. PubMed ID: 3044997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human microvascular endothelial cells resist Shiga toxins by IFN-gamma treatment in vitro.
    Yoshida T; Sugiyama T; Koide N; Mori I; Yokochi T
    Microbiology (Reading); 2003 Sep; 149(Pt 9):2609-2614. PubMed ID: 12949184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative cytotoxicity of purified Shiga-like toxin-IIe on porcine and bovine aortic endothelial and human colonic adenocarcinoma cells.
    Valdivieso-Garcia A; MacLeod DL; Clarke RC; Gyles CL; Lingwood C; Boyd B; Durette A
    J Med Microbiol; 1996 Nov; 45(5):331-7. PubMed ID: 8918947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New aspects in the pathogenesis of enteropathic hemolytic uremic syndrome.
    Karch H; Friedrich AW; Gerber A; Zimmerhackl LB; Schmidt MA; Bielaszewska M
    Semin Thromb Hemost; 2006 Mar; 32(2):105-12. PubMed ID: 16575685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High level expression of Shiga toxin B subunit of Shigella dysenteriae serotype 1 in Escherichia coli.
    Su G; Li F; Huang P; Rui X; Huang C
    Chin J Biotechnol; 1993; 9(1):49-55. PubMed ID: 8155839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative evaluation of apoptosis induced by Shiga toxin 1 and/or lipopolysaccharides in human monocytic and macrophage-like cells.
    Harrison LM; Cherla RP; van den Hoogen C; van Haaften WC; Lee SY; Tesh VL
    Microb Pathog; 2005; 38(2-3):63-76. PubMed ID: 15748808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the effects of Shiga-like toxin 1 on cytokine- and butyrate-treated human umbilical and saphenous vein endothelial cells.
    Keusch GT; Acheson DW; Aaldering L; Erban J; Jacewicz MS
    J Infect Dis; 1996 May; 173(5):1164-70. PubMed ID: 8627068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial precursor cells as a model of tumor endothelium: characterization and comparison with mature endothelial cells.
    Bagley RG; Walter-Yohrling J; Cao X; Weber W; Simons B; Cook BP; Chartrand SD; Wang C; Madden SL; Teicher BA
    Cancer Res; 2003 Sep; 63(18):5866-73. PubMed ID: 14522911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Responses of human intestinal microvascular endothelial cells to Shiga toxins 1 and 2 and pathogenesis of hemorrhagic colitis.
    Jacewicz MS; Acheson DW; Binion DG; West GA; Lincicome LL; Fiocchi C; Keusch GT
    Infect Immun; 1999 Mar; 67(3):1439-44. PubMed ID: 10024592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial heterogeneity in Shiga toxin receptors and responses.
    Obrig TG; Louise CB; Lingwood CA; Boyd B; Barley-Maloney L; Daniel TO
    J Biol Chem; 1993 Jul; 268(21):15484-8. PubMed ID: 8340376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shiga-toxin-induced firm adhesion of human leukocytes to endothelium is in part mediated by heparan sulfate.
    Geelen J; Valsecchi F; van der Velden T; van den Heuvel L; Monnens L; Morigi M
    Nephrol Dial Transplant; 2008 Oct; 23(10):3091-5. PubMed ID: 18469308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions between Shiga toxins and human polymorphonuclear leukocytes.
    Brigotti M; Carnicelli D; Ravanelli E; Barbieri S; Ricci F; Bontadini A; Tozzi AE; Scavia G; Caprioli A; Tazzari PL
    J Leukoc Biol; 2008 Oct; 84(4):1019-27. PubMed ID: 18625912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.